Geneva, July 7 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT2051260093) titled 'Double-blind comparative trial of TP-1222' on June 24.

Study Type: Interventional

Study Design: randomized controlled trial, double blind, active control, parallel assignment, treatment purpose

Primary Sponsor: Seiji Mita

Condition: Androgenetic Alopecia (Female Pattern Hair Loss)

Intervention: TP-1222 or 1% minoxidil lotion, administered at a dose of 1 mL per application, twice daily, to the affected areas of the scalp for 24 weeks....

Recruitment Status: Not Recruiting

Phase: 3

Date of First Enrollment: 05/03/2023

Target Sample Size: 360

To know more, visit https://jrct.mhlw.go.jp/latest-detai...